Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) Investor News: Investigation of Takeover by Allergan Plc

San Diego, CA -- (SBWIRE) -- 02/22/2017 -- The acquisition of Zeltiq Aesthetics Inc is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:ZLTQ shares concerning whether the takeover of Zeltiq Aesthetics Inc by Allergan plc for $56.50 per share is unfair.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.